Atorvastatin Calcium
Product Images NDC 71610-116

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71610-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 20 mg (71610 0116 45)

This is a description of a medication called Atorvastatin Calcium, which comes in the form of 20mg tablets. The pack contains 45 tablets. The rest of the text contains unreadable characters, but may be related to the product packaging or instructions.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Atorvastatin Calcium Tablets 1)

FDA Label Image

Figure 1 (Atorvastatin Calcium Tablets 2)

The provided text seems to be a statistical data set containing numbers representing cumulative incidence percentages at different time intervals collected over a period of 35 years. It also includes the hazard ratio (HR) and p-value obtained from statistical analysis. However, there is not enough information or context to provide a clear description or interpretation of the data.*

FDA Label Image

Figure 2 (Atorvastatin Calcium Tablets 3)

The text describes survival analysis data where cumulative hazard percentage, HR (Hazard Ratio), and p-value are shown for 5 different time points up to 4 years of follow-up. The data suggests that there is a statistically significant difference in survival rates between the groups being compared.*

FDA Label Image

Figure 3 (Atorvastatin Calcium Tablets 4)

This is a statistical report on the effectiveness of Atorvastatin in reducing the occurrence of major cardiovascular events. The table shows the percentages of subjects experiencing the event (not available due to the error) with Atorvastatin 10 mg and 80 mg. The hazard ratio (HR) statistic indicates that Atorvastatin 80 mg had a greater reduction in the occurrence of the event compared to the 10 mg dose. The report also includes a graph illustrating the time to the first major cardiovascular endpoint over 4 years.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.